With a new law that makes it easier for people to access experimental treatments, Montana could become the hub for the ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.

The Research Topic has been launched recently. Articles will be published on this page as soon as they become available. Manuscripts can be submitted to this Research Topic via the main journal or any ...